Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Ellard

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|September 1, 1995
Urinary nicotine metabolite excretion and lung cancer risk in a female cohortG A Ellard, F de Waard, J M Kemmeren
British Medical Journal (Clinical Research Ed.)|December 4, 1982
Who is taking their tablets?G A Ellard, P J Jenner, B W Allen
Leprosy Review|June 1, 1978
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general reviewM J Colston, G A Ellard, P T Gammon
Leprosy Review|June 1, 1988
Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazidG A Ellard, K U Kiran, J N Stanley
IARC Scientific Publications|January 1, 1986
A double-blind randomized controlled trial of the effect of a low- versus a middle-tar cigarette on respiratory symptoms--a feasibility studyH Peach, D M Hayward, D Shah, et al.
British Medical Journal (Clinical Research Ed.)|January 31, 1987
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitisG A Ellard, M J Humphries, M Gabriel, et al.
Leprosy Review|September 1, 1988
Clofazimine and dapsone compliance in leprosyG A Ellard, V K Pannikar, K Jesudasan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 10, 2001
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulationsG Pillai, G A Ellard, P J Smith, et al.
Lancet (London, England)|August 18, 1973
Pyrazinamide and other drugs in tuberculous meningitisR Forgan-Smith, G A Ellard, D Newton, et al.
British Journal of Clinical Pharmacology|August 1, 1975
The use of isoniazid as a marker to monitor the self-administration of medicamentsJ E Stark, G A Ellard, P T Gammon, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|September 1, 1995
Urinary nicotine metabolite excretion and lung cancer risk in a female cohortG A Ellard, F de Waard, J M Kemmeren
British Medical Journal (Clinical Research Ed.)|December 4, 1982
Who is taking their tablets?G A Ellard, P J Jenner, B W Allen
Leprosy Review|June 1, 1978
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general reviewM J Colston, G A Ellard, P T Gammon
Leprosy Review|June 1, 1988
Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazidG A Ellard, K U Kiran, J N Stanley
IARC Scientific Publications|January 1, 1986
A double-blind randomized controlled trial of the effect of a low- versus a middle-tar cigarette on respiratory symptoms--a feasibility studyH Peach, D M Hayward, D Shah, et al.
British Medical Journal (Clinical Research Ed.)|January 31, 1987
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitisG A Ellard, M J Humphries, M Gabriel, et al.
Leprosy Review|September 1, 1988
Clofazimine and dapsone compliance in leprosyG A Ellard, V K Pannikar, K Jesudasan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 10, 2001
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulationsG Pillai, G A Ellard, P J Smith, et al.
Lancet (London, England)|August 18, 1973
Pyrazinamide and other drugs in tuberculous meningitisR Forgan-Smith, G A Ellard, D Newton, et al.
British Journal of Clinical Pharmacology|August 1, 1975
The use of isoniazid as a marker to monitor the self-administration of medicamentsJ E Stark, G A Ellard, P T Gammon, et al.
Pageof 9